HoneyNaps Secures $11.6M to Advance AI-Powered Sleep Diagnosis Technology
HoneyNaps specializes in AI sleep data analysis and has raised a total of approximately $16.2M to date.
Company Name: HoneyNaps
Location: Seoul, South Korea
Sector: Health Technology, Artificial Intelligence
Funding Details: Raised $11.6M in funding. The round included investments from Korea Industrial Bank, Hi Investment Partners, and QUAD Investment Management.
Purpose of Investment: To expand operations and enhance development efforts.
Product Overview: HoneyNaps is a pioneering Sleep-Tech company that has developed SOMNUM, an AI-powered sleep diagnosis software. Approved by the FDA in 2023, SOMNUM analyzes biosignal data during sleep to provide rapid disease diagnoses in under five minutes. This software leverages a self-developed AI model and is designed to integrate seamlessly into any medical or healthcare setting requiring real-time, large-scale biosignal analysis.
About HoneyNaps: Established in July 2015, HoneyNaps specializes in AI sleep data analysis and has raised a total of approximately $16.2M to date. The company is committed to transforming sleep health management by providing advanced, accurate, and accessible diagnostic solutions.
